CEL-SCI CEO to Present at Dutton Associates' 'Recognizing Opportunity' SmallCap Conference in San Francisco May 30

VIENNA, Va., May 29 /PRNewswire-FirstCall/ -- CEL-SCI Corporation , a developer of cancer products, will present at Dutton Associates' "Recognizing Opportunity" SmallCap Conference. Geert Kersten, Chief Executive Officer, along with a select group of Dutton's top-followed companies, will update investment professionals on business activities, trends and current developments.

The conference will take place at The OMNI Hotel in San Francisco on Wednesday, May 30 from 7:30 a.m. to 7 p.m. Mr. Kersten will make a 30-minute presentation in the morning, followed by a short Webcast presentation (2 PM PST at http://www.jmdutton.com) and a 30-minute breakout session with investors in the afternoon. The Web broadcast will be available live on May 30, 2007 and thereafter at http://www.jmdutton.com. During the day, Mr. Kersten will be available to meet with informal groups of investment professionals during one-on-one scheduled meetings. For more conference information and registration, visit http://www.jmdutton.com.

About CEL-SCI Corporation

CEL-SCI Corporation is developing new immune system based treatments for cancer and infectious diseases. The Company has received the go-ahead from the U.S. FDA and the Canadian Regulators to conduct a Phase III clinical trial in advanced primary head and neck cancer patients with its lead product Multikine(R). CEL-SCI's other products, which are currently in pre-clinical stage and have been funded with U.S. government support, have shown protection against a number of diseases in animal tests and are currently being tested against diseases associated with bio-defense and avian flu. The Company has operations in Vienna, Virginia and Baltimore, Maryland.

About Dutton Associates

Dutton Associates, an international issuer-paid equity research firm, offers independent, fundamental research on over 120 small-cap public companies. Dutton's 29 analysts are primarily CFA charterholders with, on average, over 20 years of experience at the major securities firms. For more information, visit http://www.jmdutton.com.

CEL-SCI Corporation

CONTACT: Gavin de Windt of CEL-SCI Corporation, +1-703-506-9460

Back to news